Intermolecular cross-talk between the prostaglandin E2 receptor (EP)3 of subtype and thromboxane A(2) receptor signalling in human erythroleukaemic cells

Br J Pharmacol. 2009 Oct;158(3):830-47. doi: 10.1111/j.1476-5381.2009.00351.x. Epub 2009 Aug 20.

Abstract

Background and purpose: In previous studies investigating cross-talk of signalling between prostaglandin (PG)E(2) receptor (EP) and the TPalpha and TPbeta isoforms of the human thromboxane (TX)A(2) receptor (TP), 17-phenyl trinor PGE(2)-induced desensitization of TP receptor signalling through activation of the AH6809 and SC19220-sensitive EP(1) subtype of the EP receptor family, in a cell-specific manner. Here, we sought to further investigate that cross-talk in human erythroleukaemic (HEL) 92.1.7 cells.

Experimental approach: Specificity of 17-phenyl trinor PGE(2) signalling and its possible cross-talk with signalling by TPalpha/TPbeta receptors endogenously expressed in HEL cells was examined through assessment of agonist-induced inositol 1,4,5-trisphosphate (IP)(3) generation and intracellular calcium ([Ca(2+)](i)) mobilization.

Key results: While 17-Phenyl trinor PGE(2) led to activation of phospholipase (PL)Cbeta to yield increases in IP(3) generation and [Ca(2+)](i), it did not desensitize but rather augmented that signalling in response to subsequent stimulation with the TXA(2) mimetic U46619. Furthermore, the augmentation was reciprocal. Signalling by 17-phenyl trinor PGE(2) was found to occur through AH6809- and SC19920-insensitive, Pertussis toxin-sensitive, G(i)/G(betagamma)-dependent activation of PLCbeta. Further pharmacological investigation using selective EP receptor subtype agonists and antagonists confirmed that 17-phenyl trinor PGE(2)-mediated signalling and reciprocal cross-talk with the TP receptors occurred through the EP(3), rather than the EP(1), EP(2) or EP(4) receptor subtype in HEL cells.

Conclusions and implications: The EP(1) and EP(3) subtypes of the EP receptor family mediated intermolecular cross-talk to differentially regulate TP receptor-mediated signalling whereby activation of EP(1) receptors impaired or desensitized, while that of EP(3) receptors augmented signalling through TPalpha/TPbeta receptors, in a cell type-specific manner.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid / pharmacology
  • Calcium / metabolism
  • Cell Line
  • Cell Line, Tumor
  • Dinoprostone / analogs & derivatives
  • Dinoprostone / pharmacology
  • Enzyme Activation
  • GTP-Binding Protein alpha Subunits / physiology
  • Humans
  • Inositol 1,4,5-Trisphosphate / biosynthesis
  • Phospholipase C beta / metabolism
  • Protein Isoforms / biosynthesis
  • Receptor Cross-Talk
  • Receptors, Prostaglandin E / agonists
  • Receptors, Prostaglandin E / antagonists & inhibitors
  • Receptors, Prostaglandin E / biosynthesis
  • Receptors, Prostaglandin E / physiology*
  • Receptors, Prostaglandin E, EP1 Subtype
  • Receptors, Prostaglandin E, EP3 Subtype
  • Receptors, Thromboxane A2, Prostaglandin H2 / physiology*
  • Signal Transduction

Substances

  • 17-phenyltrinorprostaglandin E2
  • GTP-Binding Protein alpha Subunits
  • PTGER1 protein, human
  • PTGER3 protein, human
  • Protein Isoforms
  • Receptors, Prostaglandin E
  • Receptors, Prostaglandin E, EP1 Subtype
  • Receptors, Prostaglandin E, EP3 Subtype
  • Receptors, Thromboxane A2, Prostaglandin H2
  • sulprostone
  • 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
  • Inositol 1,4,5-Trisphosphate
  • Phospholipase C beta
  • Dinoprostone
  • Calcium